Cite
HARVARD Citation
Clark, W. et al. (n.d.). A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. British journal of haematology. pp. 208-217. [Online].